News
This title is part of a longer publication history. The full run of this journal will be searched. TITLE HISTORY A title history is the publication history of a journal and includes a listing of the ...
The data from the abstract of the study at ASCO shows that Keytruda plus chemo improved progression-free survival (PFS) to 9.7 months, compared to 5.6 months for chemo alone, which was a ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results